Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
| Status: | Completed |
|---|---|
| Conditions: | Cognitive Studies, Cognitive Studies, Depression, Blood Cancer, Blood Cancer, Leukemia |
| Therapuetic Areas: | Oncology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 60 - 120 |
| Updated: | 4/21/2016 |
| Start Date: | June 2007 |
| End Date: | January 2012 |
Inpatient Functional and Cognitive Assessment in Older Adults With Acute Myelogenous Leukemia
RATIONALE: Learning about physical ability and mental function over time in older patients
with acute myeloid leukemia may help doctors learn about the long-term effects of treatment
and plan the best treatment.
PURPOSE: This clinical trial is assessing physical and mental status in older patients with
newly diagnosed acute myeloid leukemia.
with acute myeloid leukemia may help doctors learn about the long-term effects of treatment
and plan the best treatment.
PURPOSE: This clinical trial is assessing physical and mental status in older patients with
newly diagnosed acute myeloid leukemia.
OBJECTIVES:
Primary
- Test the feasibility of pre-treatment, bedside assessment of functional and cognitive
status in older adults with newly diagnosed acute myeloid leukemia (AML).
Secondary
- Obtain preliminary data regarding the predictive value of pre-treatment, bedside
assessment of functional and cognitive status on overall survival, length of
hospitalization and early death.
OUTLINE: This is a prospective study.
At baseline, patients complete questionnaires including the Vulnerable Elders Survey
(functional status), the Mini-Mental Status Exam (cognition), and the Center for
Epidemiologic Studies-Depression. Patients also undergo physical function testing via the
Short Physical Performance Battery and hand grip strength. Further information parameters
are obtained by periodic medical chart reviews.
Patients are followed every 3 months for up to 2 years.
Primary
- Test the feasibility of pre-treatment, bedside assessment of functional and cognitive
status in older adults with newly diagnosed acute myeloid leukemia (AML).
Secondary
- Obtain preliminary data regarding the predictive value of pre-treatment, bedside
assessment of functional and cognitive status on overall survival, length of
hospitalization and early death.
OUTLINE: This is a prospective study.
At baseline, patients complete questionnaires including the Vulnerable Elders Survey
(functional status), the Mini-Mental Status Exam (cognition), and the Center for
Epidemiologic Studies-Depression. Patients also undergo physical function testing via the
Short Physical Performance Battery and hand grip strength. Further information parameters
are obtained by periodic medical chart reviews.
Patients are followed every 3 months for up to 2 years.
DISEASE CHARACTERISTICS:
- Pathologically confirmed newly diagnosed acute myeloid leukemia
- Planned induction chemotherapy
- Inpatient status
PATIENT CHARACTERISTICS:
- No requirement for intensive care unit support
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior therapy for acute myeloid leukemia
We found this trial at
1
site
1 Medical Center Blvd
Winston-Salem, North Carolina 27103
Winston-Salem, North Carolina 27103
(336) 716-2011
Wake Forest University Comprehensive Cancer Center Our newly expanded Comprehensive Cancer Center is the region’s...
Click here to add this to my saved trials
